GRB10 and acute myeloid leukemia: Since long-term culturing of AML blasts is not practical in the clinic, these differentially expressed genes (Figure 5; Table 4) and especially GRB10 might act as biomarkers in order to identify patients with a high fraction of long-term proliferating cells and, thus, worsened prognosis.